Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-10T06:46:43.941Z Has data issue: false hasContentIssue false
  • English
  • Français

Psychopathology measured by established self-rating scales and correlated to serotonin measures in patients with fibromyalgia

Published online by Cambridge University Press:  16 April 2020

NJ Krag ,
J Nørregaard ,
I Hindberg ,
JK Larsen  and
B Danneskiold-Samsøe
NJ Krag*
Affiliation:
Departments of Psychiatry, Rheumatology and Clinical Chemistry, Frederiksberg Hospital, Copenhagen, Denmark
J Nørregaard
Affiliation:
Departments of Psychiatry, Rheumatology and Clinical Chemistry, Frederiksberg Hospital, Copenhagen, Denmark
I Hindberg
Affiliation:
Departments of Psychiatry, Rheumatology and Clinical Chemistry, Frederiksberg Hospital, Copenhagen, Denmark
JK Larsen
Affiliation:
Departments of Psychiatry, Rheumatology and Clinical Chemistry, Frederiksberg Hospital, Copenhagen, Denmark
B Danneskiold-Samsøe
Affiliation:
Departments of Psychiatry, Rheumatology and Clinical Chemistry, Frederiksberg Hospital, Copenhagen, Denmark
*
*Correspondence and reprints: Dr NJ Krag, Søbredden 36F, 2820 Gentofte, Denmark.
Get access

Summary

The objective of the study was to evaluate the presence of psychopathology in fibromyalgia patients compared to a control group of rheumatic patients with pain. Forty-nine fibromyalgia patients and 33 controls were evaluated using established self-rating scales. Serotonin was determined using a radioenzymatic method. Fibromyalgia patients scored significantly higher than the controls on the majority of the subscales on the SCL-90, the two subscales on the Spielberger State and Trait Anxiety Inventory, the GHQ 12 scale and on a visual analogue pain scale. In a multivariate analysis the somatization dimension followed by the state anxiety accounted for the highest difference. Platelet-poor plasma serotonin, platelet serotonin and platelet uptake index were not significantly different between the groups. In conclusion, fibromyalgia patients presented quantitatively more psychopathology than the control group on a wide range of psychopathologic axes, and this cannot solely be accounted for by their higher level of pain.

Keywords

fibromyalgiaself-rating scalespsychiatrydepressionanxietypain-evaluation scalesserotonin
Type
Original article
Information
European Psychiatry , Volume 10 , Issue 8 , 1995 , pp. 404 - 409
Copyright
Copyright © Elsevier, Paris 1995

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ahles, TAYunus, MBMasi, ATIs chronic pain a variant of depressive disease? The case of primary fibromyalgia syndrome. Pain 1987; 29: 105–11CrossRefGoogle ScholarPubMed
Ahles, TAKhan, SAYunus, MBSpiegel, DAMasi, ATPsychiatric status of patients with primary fibromyalgia, patients with rheumatoid arthritis, and subjects without pain: a blind comparison of DSM-III diagnoses Am J Psychiatry 1991; 148: 1721–6Google ScholarPubMed
Arnett, FCEdworthy, SMBloch, DA, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1987; 31: 315–24Google Scholar
Banks, MHValidation of the General Health Questionnaire in a young community sample. Psychol Med 1983; 13: 349–53Google Scholar
Bech, PRating scales for psychopathology, health status and quality of life Berlin: Springer Verlag, 1993CrossRefGoogle Scholar
Bech, PAllerup, PMaier, WAlbus, MLavori, PAyuso, JLThe Hamilton scales the Hopkins Symptom Checklist (SCL-90). A cross-national validity study in patients with panic disorders. Br J Psychiatry 1992; 160: 206–11Google ScholarPubMed
Bennett, RMGatter, RACampbell, SMAndrews, RPClark, SRScarola, JAA comparison of cyclobenzaprine and placebo in the management of fibrositis. A double-blind controlled study. Arthritis Rheum 1988; 31: 1535–42CrossRefGoogle ScholarPubMed
Bimie, DJKnipping, AAvan Rijswijk, MHde Blecourt, ACde Voogd, NPsychological aspects of fibromyalgia compared with chronic and nonchronic pain. J Rheumatol 1991; 18: 1845–8Google Scholar
Carette, SBell, MJReynolds, WJ, et al. Comparison of amitriptyline, cyclobenzaprine placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial. Arthritis Rheum 1994; 37: 32–40CrossRefGoogle ScholarPubMed
Carette, SMcCain, GABell, DAFam, AGEvaluation of amitriptyline in primary fibrositis. A double-blind, placebocontrolled study. Arthritis Rheum 1986; 29: 655–9CrossRefGoogle Scholar
Clark, SCampbell, SMForehand, METindall, EABennett, RMClinical characteristics of fibrositis. II. A “blinded,” controlled study using standard psychological tests. Arthritis Rheum 1985; 28: 132–7CrossRefGoogle Scholar
Derogatis, LRSCL-90-R administration, scoring and procedures manual, Baltimore: Clinical psychometric research, 1983Google Scholar
Derogatis, LRCleary, PConfirmation of the dimensional structure of the SCL-90: a study in construct validation. J Clin Psycol 1977; 33: 981–93.0.CO;2-0>CrossRefGoogle Scholar
Goldenberg, DLPsychologic studies in fibrositis. Am J Med 1986; 81: 67–70CrossRefGoogle ScholarPubMed
Goldenberg, DLFelson, DTDinerman, HA randomized, controlled trial of amitriptyline and naproxen in the treatment of patients with fibromyalgia. Arthritis Rheum 1986; 29: 1371–7Google ScholarPubMed
Hindberg, ISerotonin In: Bergmayer, HU, ed. Methods of enzymatic analysis, vol 3. Weinheim: Verlag Chemie GmbH, 1985 556–65Google Scholar
Hindberg, INaesh, OSerotonin concentration in plasma and variation during the menstrual cycle. Clin Chem 1992; 38: 2087–9Google Scholar
Houvenagel, EForzy, GLeloire, O, et al. Cerebrospinal fluid monoamines in primary fibromyalgia. Rev Rhum Mal Osteoartic 1990; 57: 21–3Google ScholarPubMed
Hudson, JIHudson, MSPliner, LFGoldenberg, DLPope, HGJFibromyalgia and major affective disorder: a controlled phenomenology and family history study. Am J Psychiatry 1985; 142: 441–6Google ScholarPubMed
Hudson, JIGoldenberg, DLPope, HGJKeck, PEJSchlesinger, LComorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med 1992; 92: 363–7CrossRefGoogle ScholarPubMed
Kirmayer, LJRobbins, JMKapusta, MASomatization and depression in fibromyalgia syndrome. Am J Psychiatry 1988; 145: 950–4Google ScholarPubMed
Krag, NJNørregaard, JLarsen, JKDanneskiold-Samsøe, BA blinded, controlled evaluation of anxiety and depressive symptoms in patients with fibromyalgia, as measured by standardized psychometric interview scales. Acta Psychiatr Scand 1994; 89: 370–5CrossRefGoogle ScholarPubMed
Loldrup, DLangemark, MHansen, HJ, et al. The validity of the Melancholia Scale (MES) in predicting outcome of antidepressants in chronic idiopatic pain disorders. Eur Psychiatry 1991; 6: 119–25CrossRefGoogle Scholar
Mikkelsson, MLatikka, PKautiainen, HIsomeri, RIsomaki, HMuscle and bone pressure pain threshold and pain tolerance in fibromyalgia patients and controls. Arch Phys Med Rehabil 1992; 73: 814–18Google ScholarPubMed
Moldofsky, HRheumatic pain modulation syndrome: the interrelationships between sleep, central nervous system serotonin, and pain. Adv Neurol 1982; 33: 51–7Google ScholarPubMed
Payne, TCLeavitt, FGarron, , et al. Fibrositis and psychologic disturbance. Arthritis Rheum 1982; 25: 213–17CrossRefGoogle ScholarPubMed
Piergiacomi, GBlasetti, PBerti, CErcolani, MCervini, CPersonality pattern in rheumatoid arthritis and fibromyalgic syndrome. Psychological investigation. Z Rheumatol 1989; 48: 288–93Google ScholarPubMed
Quimby, LGGratwick, GMWhitney, CDBlock, SRA randomized trial of cyclobenzaprine for the treatment of fibromyalgia. J Rheumatol 1989; 19: 140–3(suppl)Google ScholarPubMed
Russell, IFVipraio, GAMorgan, WWBowden, CLIs there a metabolic basis for the fibrositis syndrome? Am J Med 1986; 81: 50–4CrossRefGoogle Scholar
Russell, UMichalek, JEVipraio, GAFletcher, EMJavors, MABowden, CAPlatelet 3H-imipramine uptake receptor density and serum serotonin levels in patients with fibromyalgia/fibrositis syndrome J Rheumatol 1992; 19: 104–9Google ScholarPubMed
Russell, IJVaeroy, HJavors, MNyberg, FCerebrospinal fluid biogenic amine metabolites in fibromyalgia/fibrositis syndrome and rheumatoid arthritis. Arthritis Rheum 1992a; 35: 550–6CrossRefGoogle ScholarPubMed
Scudds, RARollman, GBHarm, MMcCain, GAPain perception and personality measures as discriminators in the classification of fibrositis. J Rheumatol 1987; 14: 563–9Google ScholarPubMed
Scudds, RATrachsel, LCLuckhurst, BJPercy, JSA comparative study of pain, sleep quality and pain responsiveness in fibrositis and myofascial pain syndrome. J Rheumatol 1989; 19: (suppl): 120–6Google ScholarPubMed
Smythe, HANonarticular rheumatism and psychogenic musculosceletal syndromes. In: McCarty, DJArthritis and allied conditions. A textbook of rheumatology Philadelphia: Lea & Fibiger, 1979; 881–91Google Scholar
Spielberger, CDGorsuch RLLushene, RESTAI manual for the State and Trait Anxiety Inventory. Palo Alto: Consulting Psychologists Press, 1970Google Scholar
Wolfe, FCathey, MA, Kleinheksel, et al. Psychological status in primary fibrositis and fibrositis associated with rheumatoid arthritis. J Rheumatol 1984; 11: 500–6Google ScholarPubMed
Wolfe, FSmythe, HAYunus, MB, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia Report of the Multicenter Criteria Committee Arthritis Rheum 1990; 33: 160–72Google ScholarPubMed
Yunus, MMasi, ATCalabro, JJMiller, KAFeigenbaum, SLPrimary fibromyalgia (fibrositis): clinical study of 50 patients with matched normal controls. Semin Arthritis Rheum 1981; 11: 151CrossRefGoogle ScholarPubMed
Submit a response

Comments

No Comments have been published for this article.